Clinical Trial Update: Intensified Rituimab Prephase Before FCR in Untreated B-CLL [Phase 2]

View source ↗

Summary

A phase 2 trial of intensified rituximab prephase before FCR therapy in untreated chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Rituxan (rituximab)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: B-cell Chronic Lymphocytic Leukemia CLL | Phase 2 | Status: COMPLETED